City Drug House Exporters I Hepatitis Medicines Suppliers to Washington , USA
City Drug House Exporters supplies and exports high-quality hepatitis medicines from India to Washington, USA with trusted pharma solutions and timely global delivery.
HEPCDAC 60 mg tablet contains Daclatasvir, a direct-acting antiviral drug. It belongs to the Hepatitis C virus (HCV) NS5A inhibitor class and is used in combination with other medications (e.g., Sofosbuvir) to treat chronic Hepatitis C infection by disrupting viral replication and preventing the virus from multiplying.
Mechanism of Action
Target: Daclatasvir inhibits the function of the HCV NS5A protein, which is a critical, multi-functional protein essential for viral RNA replication and virion assembly.
Action: By binding to this protein, Daclatasvir halts the replication cycle and inhibits the spread of the virus to healthy liver cells.
Pharmacokinetics
Absorption: It is administered orally and is rapidly absorbed. Peak plasma concentrations are typically reached within about 2 hours post-dose.
Bioavailability: The absolute bioavailability of the 60 mg dose is approximately 67%.
Metabolism: The drug is primarily metabolized in the liver by the cytochrome P450 3A (CYP3A) system.
Excretion: It is mainly excreted via the feces 88 %and to a lesser extent via the urine 5.3 % The terminal elimination half-life is around 12 to 15 hours .
City Drug House Exporters provides:
Bulk supply for hospitals & distributors
Export to USA. Washington, INDIA
Regulatory documents (COA, MSDS, etc.)
Competitive pricing & reliable logistics
Contact for More Information :
📞 Contact City drug House Exporters from India
🌐 Websites:
https://www.citydrugexporters.com
📧 Email: citydrug123@gmail.com
📦 Business Type: Exporter | Bulk Supplier | Distributor
📲 WhatsApp: +91 9975390171
City Drug House Exporters supplies and exports high-quality hepatitis medicines from India to Washington, USA with trusted pharma solutions and timely global delivery.
HEPCDAC 60 mg tablet contains Daclatasvir, a direct-acting antiviral drug. It belongs to the Hepatitis C virus (HCV) NS5A inhibitor class and is used in combination with other medications (e.g., Sofosbuvir) to treat chronic Hepatitis C infection by disrupting viral replication and preventing the virus from multiplying.
Mechanism of Action
Target: Daclatasvir inhibits the function of the HCV NS5A protein, which is a critical, multi-functional protein essential for viral RNA replication and virion assembly.
Action: By binding to this protein, Daclatasvir halts the replication cycle and inhibits the spread of the virus to healthy liver cells.
Pharmacokinetics
Absorption: It is administered orally and is rapidly absorbed. Peak plasma concentrations are typically reached within about 2 hours post-dose.
Bioavailability: The absolute bioavailability of the 60 mg dose is approximately 67%.
Metabolism: The drug is primarily metabolized in the liver by the cytochrome P450 3A (CYP3A) system.
Excretion: It is mainly excreted via the feces 88 %and to a lesser extent via the urine 5.3 % The terminal elimination half-life is around 12 to 15 hours .
City Drug House Exporters provides:
Bulk supply for hospitals & distributors
Export to USA. Washington, INDIA
Regulatory documents (COA, MSDS, etc.)
Competitive pricing & reliable logistics
Contact for More Information :
📞 Contact City drug House Exporters from India
🌐 Websites:
https://www.citydrugexporters.com
📧 Email: citydrug123@gmail.com
📦 Business Type: Exporter | Bulk Supplier | Distributor
📲 WhatsApp: +91 9975390171
Keywords
